LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 11288 | 11155 | 1.0119 | 1.0140 |
MCF 10A | PIK-93 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 11351 | 11155 | 1.0175 | 1.0206 |
MCF 10A | KIN001-043 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 10973 | 11155 | 0.9836 | 0.9807 |
MCF 10A | Alpelisib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 9524 | 11155 | 0.8537 | 0.8276 |
MCF 10A | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 1259 | 11155 | 0.1129 | -0.0459 |
MCF 10A | A443654 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 3893 | 11155 | 0.3490 | 0.2324 |
MCF 10A | OSI-027 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 6101 | 11155 | 0.5469 | 0.4658 |
MCF 10A | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11087 | 11155 | 0.9938 | 0.9927 |
MCF 10A | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11323 | 11155 | 1.0150 | 1.0177 |
MCF 10A | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 9113 | 11155 | 0.8169 | 0.7841 |
MCF 10A | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 10018 | 11155 | 0.8981 | 0.8798 |
MCF 10A | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 2195 | 11155 | 0.1968 | 0.0530 |
MCF 10A | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10776 | 11155 | 0.9660 | 0.9599 |
MCF 10A | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 9711 | 11155 | 0.8705 | 0.8473 |
MCF 10A | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 8956 | 11155 | 0.8028 | 0.7675 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 4255 | 11155 | 0.3815 | 0.2707 |
MCF 10A | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11629 | 11155 | 1.0425 | 1.0501 |
MCF 10A | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 405 | 11155 | 0.0363 | -0.1363 |
MCF 10A | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 364 | 11155 | 0.0326 | -0.1406 |
MCF 10A | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11724 | 11155 | 1.0509 | 1.0601 |
MCF 10A | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10714 | 11155 | 0.9605 | 0.9534 |
MCF 10A | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 11256 | 11155 | 1.0090 | 1.0106 |
MCF 10A | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 9989 | 11155 | 0.8955 | 0.8768 |
MCF 10A | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 9410 | 11155 | 0.8436 | 0.8155 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 3080 | 11155 | 0.2761 | 0.1465 |